What Is Chemsex? Drugs, Risks, and Harm Reduction

Chemsex refers to the intentional use of specific drugs before or during sex to enhance the experience, and it occurs most commonly among gay, bisexual, and other men who have sex with men. A large meta-analysis pooling data from over 380,000 participants across 238 studies estimated that roughly one in five men who have sex with men had engaged in chemsex.¹ The practice sits at the intersection of recreational drug use, sexual culture, and public health, and the risks it carries go well beyond the drugs themselves.

What Sets Chemsex Apart from Recreational Drug Use

People have mixed drugs and sex for as long as both have existed, so what makes chemsex a distinct category? The term emerged in the early 2010s from gay men’s health services in London and quickly gained traction in public health literature. It does not simply mean being intoxicated during sex. Chemsex describes a specific pattern: choosing particular substances precisely because of their effects on sexual desire, stamina, and inhibition, and using them in a sexual context that is often planned in advance and may last many hours or even days.

The substances most closely associated with chemsex are methamphetamine (crystal meth), GHB/GBL, and mephedrone. But research has documented a wider pharmacological menu, including cocaine, MDMA, ketamine, the psychedelic stimulant 2C-B, and even ethyl chloride.² Erectile dysfunction medications and poppers (alkyl nitrites) frequently appear alongside these substances, though they are not usually classified as chemsex drugs on their own. The common thread is that each drug is chosen for what it does to the sexual experience: heightening arousal, dissolving anxiety, extending sessions, or intensifying physical sensation.

The Core Drugs and What They Do

Understanding the three primary chemsex substances helps make sense of both the appeal and the danger.

Methamphetamine is a powerful stimulant that floods the brain’s reward pathways with dopamine. In a sexual context, it dramatically increases desire and arousal while keeping users awake and focused for extended periods.³ Users report feelings of confidence, sociability, and emotional connection alongside the physical stimulation. The flip side is that meth is powerfully addictive, and the crash after a session can bring severe depression and exhaustion. It can be smoked, snorted, swallowed, or injected. When injected in a sexual setting, the practice is called “slamming” or “slamsex,” and it carries its own additional layer of risk.

GHB and GBL are central nervous system depressants taken as clear liquids, usually measured in small capfuls or syringes. At low doses, GHB produces euphoria, relaxation, and disinhibition. The problem is that the margin between a recreational dose and a dangerous one is remarkably thin: a plasma concentration that produces euphoria is roughly five times lower than one that can cause fatal cardiorespiratory depression.⁴ GHB is rapidly absorbed and its metabolism becomes unpredictable at higher doses, meaning the effects can escalate quickly and without warning.⁵ There is no antidote for GHB overdose; treatment is purely supportive, focused on keeping airways clear and monitoring vital signs.

Mephedrone is a synthetic stimulant with empathogenic properties, meaning it produces feelings of closeness and emotional warmth alongside stimulation. It is typically snorted or swallowed. Among the three core chemsex drugs, it appears in about 7% of men who have sex with men surveyed, making it less prevalent than GHB (about 13%) or methamphetamine (about 8%).¹

Why GHB Overdose Is the Most Acute Danger

Of the substances involved in chemsex, GHB is responsible for the most emergency situations. Because it is dosed as a liquid measured in milliliters, small errors in measurement can tip someone from euphoria into unconsciousness. Mixing GHB with alcohol or other depressants compounds this danger enormously, because both substances suppress the central nervous system through overlapping pathways.

Signs of serious GHB intoxication include sudden loss of consciousness, very slow breathing, slow heart rate, pale skin, and convulsions.⁶ Cardiac arrest is a recognized risk. Someone who “goes under” on GHB may look like they are sleeping, which in a group sex setting can lead to dangerous delays before anyone calls for help. Harm reduction guidance for chemsex spaces emphasizes never leaving someone who has collapsed alone, placing them in the recovery position, and calling emergency services immediately if breathing becomes irregular.

Infectious Disease Risks

The connection between chemsex and sexually transmitted infections is one of the most studied aspects of the practice, and the numbers are striking. A UK clinic-based study of HIV-positive men found that chemsex was associated with roughly six times the odds of condomless anal intercourse compared to non-chemsex encounters. It was also associated with about six-and-a-half times the odds of having hepatitis C and nearly three times the odds of a bacterial STI diagnosis.⁷ Slamsex (injecting drugs) carried even steeper odds for hepatitis C, at roughly nine times the rate of non-chemsex participants.p>

These patterns hold internationally. A systematic review and meta-analysis of studies from low- and middle-income countries found that men who engaged in chemsex had higher rates of condomless sex, group sex, multiple sexual partners, and both HIV and other STIs compared to men who did not.⁸ The mechanisms behind this are straightforward: the drugs lower inhibitions and impair judgment, sessions often involve multiple partners, and the extended duration means more exposure opportunities. Needle sharing during slamming adds a direct bloodborne transmission route.

A prospective cohort study following people with HIV who engaged in chemsex found that high-risk sexual behaviors persisted over time, with unprotected fisting actually increasing. Almost 30% of participants had hepatitis C antibodies at baseline, and new acute hepatitis C cases continued to emerge during follow-up. The study also identified migrants and sex workers as particularly vulnerable subgroups with higher rates of syphilis and other infections.⁹

Mental Health and Addiction

The relationship between chemsex and mental health runs in both directions. Many people who engage in chemsex describe pre-existing difficulties with self-esteem, body image, sexual confidence, or the psychological toll of navigating life as a sexual minority. The drugs offer a temporary escape from those pressures. But repeated use can deepen the very problems that drove someone to chemsex in the first place.

The neurobiological picture helps explain why. Methamphetamine, mephedrone, and GHB all act on the brain’s dopamine and reward systems. Repeated exposure can lead to neuroadaptation, where the brain adjusts to the drug-enhanced reward signal and begins to find natural pleasures less satisfying by comparison.¹⁰ This creates a cycle where sober sex feels flat or anxiety-inducing, which reinforces the perceived need for drugs.

Acute psychiatric complications are also well documented. Intense chemsex sessions, especially those involving methamphetamine, have been linked to paranoia and anxiety severe enough to require medical intervention.¹¹ Sleep deprivation during multi-day sessions compounds the risk of psychotic symptoms. GHB withdrawal, meanwhile, can produce severe anxiety, tremors, and in some cases life-threatening seizures, making it one of the few recreational drugs where stopping abruptly can be medically dangerous.

Consent and Sexual Boundaries

One of the most uncomfortable aspects of chemsex that often goes underdiscussed is its impact on consent. When everyone in a sexual encounter is heavily intoxicated, the capacity to give meaningful consent becomes genuinely compromised. A systematic scoping review on consent and violence among men in chemsex contexts found evidence of what researchers described as a “context-specific blurring of the lines of consent,” along with a concerning lack of knowledge about the centrality of consent in lawful sex.¹²

GHB poses a particular concern here. Someone who takes slightly too much may lose consciousness entirely, and the same pharmacological properties that impair capacity to consent also impair memory formation, meaning people may not remember what was done to them. GHB, GBL, mephedrone, methamphetamine, and erectile dysfunction drugs have all been documented in their capacity to impair a person’s ability to choose sexual partners and engage in consensual sex.¹³ This is not just a theoretical concern. Sexual assault in chemsex settings is reported with distressing regularity in qualitative research, and it is almost certainly underreported given the stigma surrounding the practice.

Not Just Gay Men

Chemsex emerged from and is most prevalent in communities of men who have sex with men, and the vast majority of research focuses on this population. But the practice is not exclusive to it. Reviews have noted that chemsex is also reported among heterosexual and transgender populations.¹⁴

Research on sexualized drug use among trans and non-binary people is still in its early stages but is beginning to fill in the picture. One cross-sectional study found that about 10.5% of trans and non-binary participants reported sexualized drug use, though only 1.4% reported what would be classified as chemsex specifically. The substances used were somewhat different from the classic chemsex profile: cannabis, poppers, and ecstasy were the most common, rather than methamphetamine or GHB.¹⁵ The researchers noted structural vulnerabilities specific to this population, including social marginalization, minority stress, and limited access to affirming healthcare.

Participants across all populations who engage in chemsex commonly report that they expect the drugs to positively affect their sexual encounters, enhancing confidence, pleasure, and connection.¹⁶ HIV-positive men appear to be more likely to engage in chemsex than HIV-negative men, which may partly reflect the role of internalized stigma and the desire to manage anxiety around sex and serostatus disclosure.

The Role of Apps and Digital Platforms

Chemsex does not happen spontaneously most of the time. It is frequently planned and coordinated through geolocation-based social networking apps popular among men who have sex with men. A scoping review of how these apps intersect with sexualized drug use identified several key dynamics: the apps facilitate finding chemsex partners, coordinating group sessions, sourcing drugs, and communicating through coded language that signals interest in chemsex without stating it openly.¹⁷

Terms like “PNP” (party and play), “HnH” (high and horny), “Tina” (methamphetamine), and the capital-letter “T” are common shorthand visible on profiles. This coded ecosystem makes chemsex simultaneously more accessible and more invisible to outsiders. It also creates an opportunity: the same digital infrastructure that facilitates chemsex can be used to deliver harm reduction messages where people are actually making decisions, in the apps themselves.

Harm Reduction in Practice

Harm reduction for chemsex operates on the principle that telling people to simply stop is ineffective and often counterproductive. Instead, practical strategies aim to reduce the most dangerous aspects of the practice while meeting people where they are.

Pre-exposure prophylaxis (PrEP) for HIV prevention is one of the clearest success stories. A meta-analysis found that overall PrEP use among gay, bisexual, and other men who have sex with men who engaged in chemsex was about 39%. Those who had ever engaged in chemsex were more than three times as likely to be on PrEP compared to those who had not, suggesting that awareness of risk does translate into protective behavior for a substantial portion of this group.¹⁸ Still, that means roughly 60% are not using PrEP, leaving significant room for improvement.

Beyond PrEP, practical harm reduction includes GHB dosing guidance (using syringes for accurate measurement, timing redoses carefully, never mixing with alcohol), providing clean needles for those who slam, regular STI and hepatitis screening, and ensuring people in chemsex settings know basic first aid for GHB overdose. Some sexual health clinics in the UK have developed specialized chemsex services: a cross-sectional survey found that 80% of sexual health clinics had seen patients reporting chemsex, and two-thirds identified a demand for local chemsex-specific services. The most commonly used interventions were brief advice and referral to substance misuse services.

Why People Struggle to Get Help

Despite the clear health risks, many people involved in chemsex delay or avoid seeking healthcare. The barriers are layered. Stigma is the most prominent: people feel shame not just about drug use but about their sexuality, the nature of their sexual encounters, or both at once. The multi-dimensionality of chemsex complicates things further, because someone dealing with chemsex-related problems may need sexual health services, addiction support, and mental health care simultaneously, and these services are often siloed.¹⁹

There is also a widespread perception that mainstream healthcare providers lack the cultural competence to handle chemsex-related concerns without judgment. People worry that clinicians will be shocked, will not understand the context, or will respond with moralistic advice rather than practical help.²⁰ For migrants and sex workers within chemsex settings, additional barriers around immigration status, language, and criminalization of their activities make the situation even more fraught.

Peer-Led Interventions and What Works

Given the barriers to traditional healthcare, some of the most promising approaches to chemsex harm reduction come from within the community itself. Peer-led programs employ people with personal experience of chemsex to deliver support and education. The advantage is immediate: peers understand the culture, speak its language, and can establish trust in ways that clinicians from outside the community often cannot.

An evaluation of one such program, M3THOD, found that participants valued the intervention specifically because it addressed needs that sexual health, mental health, and drug and alcohol services had all failed to meet individually. Participants reported that peers’ personal experience of chemsex built rapid rapport and helped mitigate the shame that typically prevents people from seeking help.²¹

In Australia, a community-led harm reduction initiative took a similar approach, using culturally relevant language and imagery designed by peers, operating within what they described as a “pleasure-positive” framework. Rather than framing all drug use as pathological, the program acknowledged the role of pleasure and worked to reduce harm without demanding abstinence as a precondition for engagement. The results included increased service uptake, strong community participation, and the formal recognition of gay and bisexual men as a priority population in local drug and alcohol strategies.²²

The Problem of Sober Sex After Chemsex

One consequence of chemsex that receives less attention than infection risk or overdose is what happens when someone tries to stop. For people who have spent months or years having sex exclusively under the influence of drugs that dramatically enhance desire, arousal, and stamina, returning to sober sex can be genuinely distressing.

An Italian study exploring sexual response among men who had engaged in chemsex found a revealing split. While chemsex was associated with heightened sexual desire and subjective arousal, prolonged session duration, and intensified feelings of intimacy and pleasure, it also brought erection and ejaculation difficulties. Sober sex, by contrast, was described as more intimate but was significantly affected by performance anxiety. The researchers observed that chemsex seemed to embody a model of transgressive, exciting sex, while sober sex felt smaller and more vulnerable by comparison. The gap between the two experiences made returning to sober sex feel like a loss rather than a recovery.

This phenomenon has real implications for treatment. Addiction services that focus purely on achieving abstinence from drugs may miss the sexual dimension entirely. Someone who stops using methamphetamine but finds themselves unable to enjoy or even have sex without it is likely to relapse. Effective support needs to address the sexual rehabilitation component directly: rebuilding sexual confidence, managing performance anxiety, and relearning intimacy without chemical enhancement. Programs that integrate sexual health support alongside addiction treatment are still relatively rare, but the evidence increasingly suggests they are what many chemsex users actually need.